These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5430911)

  • 21. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin therapy in peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Skawiński S; Głuszko P; Korbut R
    Thromb Res; 1980 Jul 1-15; 19(1-2):191-9. PubMed ID: 6108623
    [No Abstract]   [Full Text] [Related]  

  • 23. [Our experience in antalgic therapy of peripheral arteriopathies].
    Tufano R; Portolano F; Bimonte D
    Rass Int Clin Ter; 1971 Mar; 51(6):370-4. PubMed ID: 5553226
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of 1-4-dihydrazinophthalazine on arterial circulation of the limbs in normal and artery disease patients].
    Leoni E
    Gazz Int Med Chir; 1965 Sep; 69(17):1468-74. PubMed ID: 5837540
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
    Zhang GS
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 27. Treating principles and methods of traditional Chinese medicine in treatment of peripheral vascular diseases.
    Zhang Y; Chen Z; Liu Y; Zhang Y
    J Tradit Chin Med; 2001 Jun; 21(2):130-3. PubMed ID: 11498903
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of peripheral ischemizing arteriopathies with diisopropylammonium dichloroethanoate (Diedì), a drug with action prevalent on respiratory tissue metabolism].
    Maggi GC; Tartara A
    Minerva Cardioangiol; 1965 Jul; 13(7):382-3. PubMed ID: 5838538
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
    Raso AM; Silvestrini P
    Minerva Med; 1973 Mar; 64(19):961-9. PubMed ID: 4703313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical use of thymoxamine in peripheral arterial pathology].
    Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
    Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
    Chrzanowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution to the therapy of juvenile and arteriosclerotic chronic peripheral obliterating artery diseases with a new sympatholytic drug].
    Stoppani L; Lo Cuoco A
    Minerva Cardioangiol; 1966 Mar; 14(3):163-5. PubMed ID: 5937431
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and hemodynamic aspects induced by eledoisin. Plethysmographic study of variations of flow in some forms of obliterating arterial disease of the legs, during intra-arterial infusion of eledoisin].
    Chiampo L; La Greca G; Ferrari S; Novarini A
    Minerva Cardioangiol; 1965 Jul; 13(7):375-82. PubMed ID: 5838537
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
    Stepanova-Nikitina GG; Rage KM
    Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
    [No Abstract]   [Full Text] [Related]  

  • 39. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mydocalm administered in electrophoresis].
    Chmielewski F
    Pol Tyg Lek; 1971 Jul; 26(30):1170-2. PubMed ID: 5092988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.